Loading…
Reported covered position: Cong. John Shadegg - Legislative Assistant, Subcommittee Staff Director, Chief of Staff, Policy Director; Centers for Medicare and Medicaid Services - Senior Counselor, Chief of Staff
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Innovation and R&D Competitiveness Act of 2023
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
American Innovation and R&D Competitiveness Act of 2023
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2023 · fourth_quarter · 4T
Inflation Reduction Act Rx Provisions Implementation; S. 476, Maintaining Investments in New Innovation Act
Pandemic Preparedness Funding, Influenza Preparedness; COVID-19 Response and Therapeutics Procurement and Distribution; FY 2024 Labor-HHS Appropriations; Pandemic and All-Hazards Preparedness Act Reauthorization
Source: Senate LDA
American Innovation and R&D Competitiveness Act of 2023
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
Maintaining Investments in New Innovation Act
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
Inflation Reduction Act Rx Provisions Implementation; S. 476, Maintaining Investments in New Innovation Act
Maintaining Investments in New Innovation Act
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
Inflation Reduction Act Rx Provisions Implementation; S. 476, Maintaining Investments in New Innovation Act
American Innovation and Jobs Act
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
American Innovation and Jobs Act
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
American Innovation and Jobs Act
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
American Innovation and Jobs Act
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 866, American Innovation and Jobs Act
American Innovation and R&D Competitiveness Act of 2021
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing; H.R. 1304, American Innovation and R&D Competitiveness Act
American Innovation and R&D Competitiveness Act of 2021
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing; H.R. 1304, American Innovation and R&D Competitiveness Act
Consolidated Appropriations Act, 2022
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 3799 PREVENT Pandemics Act; H.R. 2471 Consolidated Appropriations Act, COVID Supplemental Appropriations Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-9 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act.
Consolidated Appropriations Act, 2023
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; H.R. 2617, Consolidated Appropriations Act for FY 2023
Inflation Reduction Act of 2022
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations; H.R. 5376, Inflation Reduction Act
S. 3799 PREVENT Pandemics Act; H.R. 2471 Consolidated Appropriations Act, COVID Supplemental Appropriations Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-9 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act.
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations.
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; H.R. 2617, Consolidated Appropriations Act for FY 2023
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations; H.R. 5376, Inflation Reduction Act
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing; H.R. 1304, American Innovation and R&D Competitiveness Act
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing; H.R. 1304, American Innovation and R&D Competitiveness Act
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing
To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing; H.R. 1304, American Innovation and R&D Competitiveness Act
To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing; H.R. 1304, American Innovation and R&D Competitiveness Act
To amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities.
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations.
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations; H.R. 5376, Inflation Reduction Act
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; H.R. 2617, Consolidated Appropriations Act for FY 2023
S. 3799 PREVENT Pandemics Act; H.R. 2471 Consolidated Appropriations Act, COVID Supplemental Appropriations Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-9 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act.
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations; H.R. 5376, Inflation Reduction Act
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations.
S. 3799 PREVENT Pandemics Act; H.R. 2471 Consolidated Appropriations Act, COVID Supplemental Appropriations Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-9 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act.
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; H.R. 2617, Consolidated Appropriations Act for FY 2023
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; H.R. 2617, Consolidated Appropriations Act for FY 2023
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations.
S. 3799 PREVENT Pandemics Act; H.R. 2471 Consolidated Appropriations Act, COVID Supplemental Appropriations Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-9 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act.
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations; H.R. 5376, Inflation Reduction Act
S. 2640, Disease X Act; S. 3258/H.R 6025, Flu Vaccine Act; Build Back Better - Prescription Drug Policy, Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurements; Pandemic Preparedness.
Providing for consideration of the bill (H.R. 4) to amend the Voting Rights Act of 1965 to revise the criteria for determining which States and political subdivisions are subject to section 4 of the Act, and for other purposes; providing for consideration of the Senate amendment to the bill (H.R. 3684) to authorize funds for Federal-aid highways, highway safety programs, and transit programs, and for other purposes; and providing for the adoption of the concurrent resolution (S. Con. Res. 14) setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031; and for other purposes.
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 2640, Disease X Act; H.Res. 601, FY 2022 Budget Resolution and Reconciliation Instructions, S. Con. Res. 14 FY 2022 Budget Resolution and Reconciliation Instructions; Prescription Policy in Budget Reconciliation; American Rescue Plan Implementation (COVID-19 Response and COVID Therapeutics Procurements), Pandemic Preparedness.
S. 2640, Disease X Act; S. 3258/H.R 6025, Flu Vaccine Act; Build Back Better - Prescription Drug Policy, Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurements; Pandemic Preparedness.
S. 2640, Disease X Act; H.Res. 601, FY 2022 Budget Resolution and Reconciliation Instructions, S. Con. Res. 14 FY 2022 Budget Resolution and Reconciliation Instructions; Prescription Policy in Budget Reconciliation; American Rescue Plan Implementation (COVID-19 Response and COVID Therapeutics Procurements), Pandemic Preparedness.
S. 2640, Disease X Act; S. 3258/H.R 6025, Flu Vaccine Act; Build Back Better - Prescription Drug Policy, Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurements; Pandemic Preparedness.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: VIR BIOTECHNOLOGY, INC. · Firm: VIR BIOTECHNOLOGY, INC.
S. 2640, Disease X Act; H.Res. 601, FY 2022 Budget Resolution and Reconciliation Instructions, S. Con. Res. 14 FY 2022 Budget Resolution and Reconciliation Instructions; Prescription Policy in Budget Reconciliation; American Rescue Plan Implementation (COVID-19 Response and COVID Therapeutics Procurements), Pandemic Preparedness.
COVID-19 Trade Related Aspects of Intellectual Property Rights Waiver
Pandemic Preparedness; Biomanufacturing
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, U.S. International Trade Commission (ITC), White House Office
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2023 · third_quarter · Q3
Inflation Reduction Act Rx Provisions Implementation; S. 476, Maintaining Investments in New Innovation Act
Pandemic Preparedness Funding, Influenza Preparedness; COVID-19 Response and Therapeutics Procurement and Distribution; FY 2024 Labor-HHS Appropriations; Pandemic and All-Hazards Preparedness Act Reauthorization
COVID-19 Trade Related Aspects of Intellectual Property Rights Waiver
Pandemic Preparedness; Biomanufacturing
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, U.S. International Trade Commission (ITC), White House Office
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2023 · second_quarter · Q2
Pandemic Preparedness; Biomanufacturing
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
COVID-19 Trade Related Aspects of Intellectual Property Rights Waiver
Inflation Reduction Act Rx Provisions Implementation
Pandemic Preparedness Funding, Influenza Preparedness; COVID-19 Response and Therapeutics Procurement and Distribution; FY 2024 Labor-HHS Appropriations; Pandemic and All-Hazards Preparedness Act Reauthorization
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, U.S. International Trade Commission (ITC), White House Office
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2023 · first_quarter · Q1
Pandemic Preparedness Funding, Influenza Preparedness; COVID-19 Response and Therapeutics Procurement and Distribution; FY 2024 Labor-HHS Appropriations; Pandemic and All-Hazards Preparedness Act Reauthorization
Inflation Reduction Act Rx Provisions Implementation
COVID-19 Trade Related Aspects of Intellectual Property Rights Waiver
S. 866, American Innovation and Jobs Act
Emergency Clinical Trials Policy; Pandemic Preparedness; Biomanufacturing
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, U.S. International Trade Commission (ITC), White House Office
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2022 · fourth_quarter · Q4
Pandemic Preparedness
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; H.R. 2617, Consolidated Appropriations Act for FY 2023
Coverage and Reimbursement of COVID-19 Therapeutics.
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing; H.R. 1304, American Innovation and R&D Competitiveness Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2022 · third_quarter · Q3
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations; H.R. 5376, Inflation Reduction Act
Coverage and Reimbursement of COVID-19 Therapeutics.
Pandemic Preparedness
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2022 · second_quarter · Q2
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing
Coverage and Reimbursement of COVID-19 Therapeutics.
Pandemic Preparedness
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2022 · first_quarter · Q1
Pandemic Preparedness
Reimbursement of COVID-19 Therapeutics
S. 3799 PREVENT Pandemics Act; H.R. 2471 Consolidated Appropriations Act, COVID Supplemental Appropriations Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-9 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2021 · fourth_quarter · Q4
S. 2640, Disease X Act; S. 3258/H.R 6025, Flu Vaccine Act; Build Back Better - Prescription Drug Policy, Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurements; Pandemic Preparedness.
Reimbursement of COVID-19 Therapeutics
Pandemic Preparedness
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2021 · third_quarter · Q3
S. 2640, Disease X Act; H.Res. 601, FY 2022 Budget Resolution and Reconciliation Instructions, S. Con. Res. 14 FY 2022 Budget Resolution and Reconciliation Instructions; Prescription Policy in Budget Reconciliation; American Rescue Plan Implementation (COVID-19 Response and COVID Therapeutics Procurements), Pandemic Preparedness.
Reimbursement of COVID-19 Therapeutics
Pandemic Preparedness
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
VIR BIOTECHNOLOGY, INC. via VIR BIOTECHNOLOGY, INC.
2021 · third_quarter · RR
BARDA/DoD Procurements, COVID-19 Response, Pandemic Preparedness, Rx Policy in Budget Reconciliation
BARDA/DoD Procurements, COVID-19 Response, Pandemic Preparedness, Rx Policy in Budget Reconciliation
BARDA/DoD Procurements, COVID-19 Response, Pandemic Preparedness, Rx Policy in Budget Reconciliation
H.R. 7410, American-Made Medicine Act; H.R. 7505, More Cures Act; Section 174 R&D Expensing; H.R. 1304, American Innovation and R&D Competitiveness Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
S. 3799 PREVENT Pandemics Act; Pandemic Preparedness Funding; COVID-19 Response and COVID-19 Therapeutics Procurement; S. 2640 Disease X Act; S. 3258/H.R. 6025 Flu Vaccine Act; FY 2023 Labor-HHS Appropriations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE